📢 𝐉𝐔𝐒𝐓 𝐈𝐍: AstraZeneca Holds Talks With Bristol Myers Squibb on Pharma Megadeal - FT - $AstraZeneca(AZN.US) $Bristol Myers Squibb(BMY.US)
Share your thoughtsWhat's on your mind?
0 / 2,000
- H
📢 𝐉𝐔𝐒𝐓 𝐈𝐍: Trump to unveil more discounted prescription drug options - CNBC - $AstraZeneca(AZN.US) $Eli Lilly(LLY.US) $Merck(MRK.US) $Abbvie(ABBV.US)
- D
CRM Trans: Organic rev. growth to re-accelerate in H2 FY ---
Below is Dolphin Research's Trans of $Salesforce(CRM.US) FY26 Q4 earnings call.
For our earnings analysis, cf. 'Salesforce: The AI replacement thesis sweeps the field — has the SaaS leader been cast aside?'Key takeaways recap
1) Q1 guidance: revenue of $11.03–11.08bn, implying reported growth of ~12–13%.Management also guides Q1 CRPO to grow ~14% YoY on a reported basis ...SalesforceConference Minutes - H
Earnings Preview | A new round of 'Earnings Storm' is coming💥
This week we will focus on star companies in various fields such as technology, catering, and pharmaceuticals.